EE200300103A - Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm - Google Patents

Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm

Info

Publication number: EE200300103A
Authority: EE; Estonia
Prior art keywords: contraception; administered
Prior art date: 2000-09-14

Application number

EEP200300103A

Other languages

English (en)

Inventor

Kulmann Hermann

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-14

Filing date

2001-09-05

Publication date

2005-02-15

2001-09-05 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2005-02-15 Publication of EE200300103A publication Critical patent/EE200300103A/et

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

EEP200300103A 2000-09-14 2001-09-05 Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm EE200300103A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10045380A DE10045380A1 (de)	2000-09-14	2000-09-14	Verfahren zur Kontrazeption und dessen Darreichungsform
PCT/EP2001/010207 WO2002022110A2 (en)	2000-09-14	2001-09-05	Contraception process and administration form for the same

Publications (1)

Publication Number	Publication Date
EE200300103A true EE200300103A (et)	2005-02-15

Family

ID=7656125

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300103A EE200300103A (et)	2000-09-14	2001-09-05	Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm

Country Status (32)

Country	Link
US (2)	US8076317B2 (et)
EP (2)	EP2153849A3 (et)
JP (3)	JP2004508398A (et)
KR (3)	KR20030031185A (et)
CN (1)	CN100560132C (et)
AR (1)	AR030737A1 (et)
AT (1)	ATE447972T1 (et)
AU (2)	AU8405201A (et)
BG (2)	BG107625A (et)
BR (1)	BR0113902A (et)
CA (1)	CA2420292C (et)
CZ (1)	CZ2003723A3 (et)
DE (2)	DE10045380A1 (et)
EA (1)	EA006875B1 (et)
EE (1)	EE200300103A (et)
HK (1)	HK1060305A1 (et)
HR (1)	HRP20030294A2 (et)
HU (1)	HUP0301042A3 (et)
IL (2)	IL154521A0 (et)
ME (1)	ME00291B (et)
MX (1)	MXPA03002070A (et)
NO (1)	NO20031152L (et)
NZ (1)	NZ524448A (et)
PE (1)	PE20020425A1 (et)
PL (1)	PL361161A1 (et)
SK (1)	SK3102003A3 (et)
TW (1)	TWI297271B (et)
UA (1)	UA93650C2 (et)
UY (1)	UY26932A1 (et)
WO (1)	WO2002022110A2 (et)
YU (1)	YU19003A (et)
ZA (1)	ZA200301359B (et)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
MY151322A (en) *	2004-04-30	2014-05-15	Bayer Ip Gmbh	Management of breakthrough bleeding in extended hormonal contraceptive regimens
AU2011226911B2 (en) *	2004-04-30	2014-06-19	Bayer Intellectual Property Gmbh	Management of breakthrough bleeding in extended hormonal contraceptive regimens
DE102004026679A1 (de) *	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026670A1 (de) *	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) *	2004-05-28	2005-12-15	Grünenthal GmbH	Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026671A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Darreichungsform zur hormonalen Kontrazeption
EP1655031A1 (de)	2004-10-08	2006-05-10	Schering AG	Dienogest enthaltendes Langzeit-Verfahren zur Empfängnisverhütung
TW200744610A (en) *	2005-06-21	2007-12-16	Organon Nv	New regimens for controlled drug delivery devices for contraception
TW200727920A (en) *	2005-06-21	2007-08-01	Organon Nv	New regimens for oral monophasic contraceptives
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
DE102006003509A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Kontrazeptivum
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
GB0623813D0 (en) *	2006-11-29	2007-01-10	Stephenson Group Ltd	Foam reduction
DE102007011486A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Arzneimittel umfassend wenigstens ein Gestagen
EP2140860A1 (en) *	2008-07-03	2010-01-06	Bayer Schering Pharma Oy	An improved method of contraception
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
CA2856520C (en)	2011-11-23	2021-04-06	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en)	2014-05-22	2016-11-17	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
WO2017173044A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd Inc.	Steroid hormone compositions in medium chain oils
CA3020153A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2365103C3 (de) *	1973-12-21	1980-08-28	Schering Ag, 1000 Berlin Und 4619 Bergkamen	V erwendung von Hormonen zur Kontrazeption
NL9301562A (nl) *	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE69532894T2 (de) *	1994-11-22	2004-09-02	Balance Pharmaceuticals, Inc., Pacific Palisades	Verfahren zur empfängnisverhütung
DE19525017A1 (de) *	1995-06-28	1997-01-02	Schering Ag	Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5897539A (en) *	1995-09-28	1999-04-27	Schering Aktiengesellschaft	Hormone replacement therapy method and hormone dispenser
WO1998004269A1 (en)	1996-07-26	1998-02-05	American Home Products Corporation	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5898032A (en) *	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy

2000
- 2000-09-14 DE DE10045380A patent/DE10045380A1/de not_active Withdrawn
2001
- 2001-09-05 KR KR10-2003-7003667A patent/KR20030031185A/ko not_active Application Discontinuation
- 2001-09-05 AU AU8405201A patent/AU8405201A/xx active Pending
- 2001-09-05 NZ NZ524448A patent/NZ524448A/en not_active IP Right Cessation
- 2001-09-05 DE DE60140462T patent/DE60140462D1/de not_active Expired - Lifetime
- 2001-09-05 BR BR0113902-9A patent/BR0113902A/pt active Search and Examination
- 2001-09-05 AU AU2001284052A patent/AU2001284052B2/en not_active Ceased
- 2001-09-05 PL PL36116101A patent/PL361161A1/xx not_active Application Discontinuation
- 2001-09-05 YU YU19003A patent/YU19003A/sh unknown
- 2001-09-05 SK SK310-2003A patent/SK3102003A3/sk not_active Application Discontinuation
- 2001-09-05 UA UA2003043067A patent/UA93650C2/ru unknown
- 2001-09-05 HU HU0301042A patent/HUP0301042A3/hu unknown
- 2001-09-05 CN CNB018155707A patent/CN100560132C/zh not_active Expired - Fee Related
- 2001-09-05 WO PCT/EP2001/010207 patent/WO2002022110A2/en active IP Right Grant
- 2001-09-05 EE EEP200300103A patent/EE200300103A/et unknown
- 2001-09-05 JP JP2002526362A patent/JP2004508398A/ja not_active Withdrawn
- 2001-09-05 ME MEP-2008-376A patent/ME00291B/me unknown
- 2001-09-05 CA CA2420292A patent/CA2420292C/en not_active Expired - Fee Related
- 2001-09-05 KR KR1020097005863A patent/KR20090033502A/ko not_active Application Discontinuation
- 2001-09-05 CZ CZ2003723A patent/CZ2003723A3/cs unknown
- 2001-09-05 EP EP09014071A patent/EP2153849A3/en not_active Ceased
- 2001-09-05 EA EA200300338A patent/EA006875B1/ru not_active IP Right Cessation
- 2001-09-05 EP EP01962996A patent/EP1317286B1/en not_active Expired - Lifetime
- 2001-09-05 US US10/380,405 patent/US8076317B2/en not_active Expired - Fee Related
- 2001-09-05 IL IL15452101A patent/IL154521A0/xx unknown
- 2001-09-05 AT AT01962996T patent/ATE447972T1/de not_active IP Right Cessation
- 2001-09-05 MX MXPA03002070A patent/MXPA03002070A/es active IP Right Grant
- 2001-09-05 KR KR1020107010166A patent/KR101240232B1/ko not_active IP Right Cessation
- 2001-09-10 PE PE2001000903A patent/PE20020425A1/es not_active Application Discontinuation
- 2001-09-11 UY UY26932A patent/UY26932A1/es not_active Application Discontinuation
- 2001-09-12 TW TW090122607A patent/TWI297271B/zh not_active IP Right Cessation
- 2001-09-14 AR ARP010104361A patent/AR030737A1/es not_active Application Discontinuation
2003
- 2003-02-18 IL IL154521A patent/IL154521A/en not_active IP Right Cessation
- 2003-02-19 ZA ZA200301359A patent/ZA200301359B/en unknown
- 2003-03-11 BG BG107625A patent/BG107625A/bg unknown
- 2003-03-13 NO NO20031152A patent/NO20031152L/no not_active Application Discontinuation
- 2003-04-14 HR HR20030294A patent/HRP20030294A2/hr not_active Application Discontinuation
2004
- 2004-05-12 HK HK04103325.6A patent/HK1060305A1/xx not_active IP Right Cessation
2011
- 2011-11-18 BG BG10111090A patent/BG111090A/bg unknown
- 2011-12-12 US US13/316,887 patent/US8536156B2/en not_active Expired - Fee Related
2012
- 2012-09-10 JP JP2012198547A patent/JP2013006866A/ja not_active Withdrawn
2013
- 2013-08-09 JP JP2013166891A patent/JP2013241456A/ja active Pending

Also Published As

Publication number	Publication date
KR20090033502A (ko)	2009-04-03
KR20100056577A (ko)	2010-05-27
BG111090A (bg)	2012-03-30
MXPA03002070A (es)	2003-06-24
EP1317286B1 (en)	2009-11-11
HUP0301042A2 (hu)	2003-10-28
PL361161A1 (en)	2004-09-20
NO20031152D0 (no)	2003-03-13
MEP37608A (en)	2011-02-10
CZ2003723A3 (cs)	2003-06-18
EP2153849A2 (en)	2010-02-17
EP1317286A2 (en)	2003-06-11
BG107625A (bg)	2003-11-28
CA2420292A1 (en)	2002-03-21
US8076317B2 (en)	2011-12-13
YU19003A (sh)	2006-05-25
NO20031152L (no)	2003-05-14
SK3102003A3 (en)	2003-09-11
US20120129823A1 (en)	2012-05-24
EP2153849A3 (en)	2011-09-14
EA006875B1 (ru)	2006-04-28
HK1060305A1 (en)	2004-08-06
DE60140462D1 (de)	2009-12-24
UA93650C2 (ru)	2011-03-10
WO2002022110A3 (en)	2002-07-04
KR101240232B1 (ko)	2013-03-07
AU8405201A (en)	2002-03-26
IL154521A (en)	2014-05-28
BR0113902A (pt)	2003-07-22
AU2001284052B2 (en)	2006-11-30
UY26932A1 (es)	2001-12-28
US8536156B2 (en)	2013-09-17
NZ524448A (en)	2005-03-24
WO2002022110A2 (en)	2002-03-21
ME00291B (me)	2011-05-10
HUP0301042A3 (en)	2010-03-29
TWI297271B (en)	2008-06-01
US20040219174A1 (en)	2004-11-04
CA2420292C (en)	2010-12-14
KR20030031185A (ko)	2003-04-18
ZA200301359B (en)	2004-02-05
JP2004508398A (ja)	2004-03-18
HRP20030294A2 (en)	2005-02-28
ATE447972T1 (de)	2009-11-15
CN100560132C (zh)	2009-11-18
JP2013241456A (ja)	2013-12-05
DE10045380A1 (de)	2002-04-04
EA200300338A1 (ru)	2003-08-28
JP2013006866A (ja)	2013-01-10
PE20020425A1 (es)	2002-06-15
IL154521A0 (en)	2003-09-17
CN1455681A (zh)	2003-11-12
AR030737A1 (es)	2003-09-03

Publication	Publication Date	Title
EE200300103A (et)	2005-02-15	Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm
AR028027A1 (es)	2003-04-23	Componente de compuestos en secciones y procedimiento para producir el mismo
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
CY2013011I1 (el)	2015-08-05	Μεθοδος χορηγησης διφωσφονικων
EE200300151A (et)	2003-06-16	Ravimitena kasutatavad antikolinergikumid ning meetodid nende valmistamiseks
PL401469A1 (pl)	2013-02-04	Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja
EE200200628A (et)	2004-04-15	Dihüdroksüestrite ja nende derivaatide valmistamismeetod
EE200200328A (et)	2003-10-15	Multi kompositsioon ja meetod
LTPA2014005I1 (lt)	2022-05-25	Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
EE200200666A (et)	2004-06-15	Meetod tsüklopropüülkarboksüülhappe estrite ja derivaatide valmistamiseks
EE05387B1 (et)	2011-02-15	KinasoliiniÁderivaadid,ÁnendeÁvalmistamismeetodÁjaÁkasutamine
EE200200715A (et)	2004-08-16	Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena
EE200300145A (et)	2003-06-16	Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
AR026046A1 (es)	2002-12-26	NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
EE200200607A (et)	2004-04-15	2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
EE200100653A (et)	2003-02-17	Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
AR028289A1 (es)	2003-04-30	Metodo para modificar la composicion de lignina y aumentar la digestibilidad in vivo de forrages
EE200200105A (et)	2003-04-15	Radiofarmatseutilised saadused ja nende valmistamise meetod
DE69900823T2 (de)	2002-08-29	Injizierbare arzneizubereitung bestehend aus paracetamol
EP1326625A4 (en)	2005-05-04	IMMUNOGENIC COMPOSITION OF HEPATITIS C AND METHODS OF USING THE SAME
ID29494A (id)	2001-08-30	Pengatasan dalam atau kaitannya terhadap pengurangan bau
EE200100544A (et)	2003-02-17	15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon
NO20030794L (no)	2003-04-22	Fremgangsmåte for legemiddelavlevering til hepatocytter av flavivirida-infeksjoner
GB0312566D0 (en)	2003-07-09	Veterinary composition for the topical treatment of traumatized or inflamed skin